SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-278378
Filing Date
2020-10-27
Accepted
2020-10-27 16:02:53
Documents
10
Period of Report
2020-12-16
Effectiveness Date
2020-10-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A d17046ddef14a.htm DEF 14A 541095
2 GRAPHIC g17046dsp2a.jpg GRAPHIC 5423
3 GRAPHIC g17046g03v42.jpg GRAPHIC 1966
4 GRAPHIC g17046g1017042551817.jpg GRAPHIC 1773
5 GRAPHIC g17046g1017042551988.jpg GRAPHIC 675
6 GRAPHIC g17046g1017042552129.jpg GRAPHIC 774
7 GRAPHIC g17046g1017042552487.jpg GRAPHIC 733
8 GRAPHIC g17046g14k01.jpg GRAPHIC 265702
9 GRAPHIC g17046g16r28.jpg GRAPHIC 51363
10 GRAPHIC g17046g23q00.jpg GRAPHIC 267287
  Complete submission text file 0001193125-20-278378.txt   1361890
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 000-50484 | Film No.: 201264151
SIC: 2834 Pharmaceutical Preparations